Numerous people in Britain are experiencing a puzzling and severe skin disorder that has stumped doctors. Sufferers report their skin becoming intensely inflamed with cracking and peeling, commonly affecting large areas of their body, yet many doctors have trouble diagnosing or treating the condition. The occurrence, called topical steroid withdrawal (TSW) or red skin syndrome, has created considerable interest on social platforms, with footage showing patients’ experiences garnering over a billion views on TikTok alone. Although it affects a increasing number of people, TSW remains so poorly understood that some doctors and dermatologists doubt whether it exists at all. Now, for the very first time, researchers in the UK are commencing a major study to investigate what is behind these mysterious symptoms and reasons why some people develop the condition whilst others do not.
The Unexplained Illness Sweeping Across the UK
Bethany Gamble’s experience exemplifies the profound effects of topical steroid withdrawal on those affected. The 21-year-old from Birmingham had managed her eczema well with steroid creams since childhood, but at eighteen, her condition deteriorated significantly. Her skin became severely inflamed and reddened, cracking and oozing whilst the itching became what she characterises as “bone deep”. Within two years, the pain had become so acute that she was unable to leave her bed, requiring round-the-clock care from her mother. Most distressing of all, Bethany experienced repeated dismissal by doctors who attributed her symptoms to standard eczema and kept prescribing the very treatments she thought were responsible for her suffering.
The medical community remains divided on how to address TSW, with significant discord about its very nature. Some experts regard it as a severe allergic response to the steroid creams that represent the standard treatment for eczema across the NHS. Others argue it constitutes a acute flare-up of current skin conditions rather than a separate syndrome, whilst a minority remain unconvinced of its existence altogether. This lack of professional consensus has left patients like Bethany trapped in a state of diagnostic limbo, struggling to access appropriate treatment. The lack of consensus has prompted Professor Sara Brown at the University of Edinburgh to set up the inaugural major UK research project examining TSW, supported by the National Eczema Society.
- Symptoms include severe inflammation, skin fissuring and persistent pruritus across the body
- Patients document “elephant skin” hardening and excessive flaking of keratinised cells
- Medical professionals frequently overlook TSW as standard eczema or refuse to acknowledge it
- The condition can be so incapacitating that sufferers become unable to perform daily activities
Living with Steroid Topical Withdrawal
From Controllable Eczema to Severe Symptoms
For many sufferers, withdrawal from topical steroids constitutes a severe decline from a previously stable dermatological condition. What starts with intermittent itching in skin creases can rapidly escalate into a full-body inflammatory response that renders patients unable to function. The transition often occurs suddenly, without warning, converting a controllable long-term condition into an severe medical emergency. People describe their skin turning intensely hot, inflamed and red, with significant cracking and weeping that requires constant attention. The physical toll is worsened by fatigue, as the relentless itching prevents sleep and recovery, establishing a vicious cycle of deterioration.
The speed at which TSW develops takes many sufferers by surprise. Those who have dealt with eczema for years, sometimes decades, are unprepared for the magnitude of symptoms that develop when their condition sharply declines. Everyday tasks become overwhelming difficulties: showering becomes unbearable, dressing requires assistance, and preserving hygiene demands substantial energy. Some patients report feeling as though their skin is being ravaged from within, with inflammation extending over their body in patterns that differ markedly to their earlier flare-ups. This marked shift often prompts sufferers to obtain emergency care, only to encounter disbelief from healthcare professionals.
The Quest for Recognition
Perhaps the cruelest aspect of topical steroid withdrawal is the medical gaslighting that frequently accompanies it. Patients presenting with serious, unexplained health issues are routinely told they merely suffer from eczema worsening, despite their insistence that this is fundamentally different from anything they’ve experienced before. Doctors frequently react by recommending higher-strength steroids or higher dosages, potentially worsening the very condition patients believe the creams caused. This pattern of rejection leaves sufferers experiencing abandonment by the medical establishment, forced to navigate their illness alone whilst being told their lived experience is invalid. Many patients report experiencing repeated invalidation, their worries disregarded as anxiety or psychological rather than genuine physiological symptoms.
The lack of professional agreement has established a significant divide between patient experience and clinical acknowledgement. Without clear diagnostic criteria or defined treatment approaches, general practitioners and skin specialists struggle to identify TSW or offer appropriate support. Some practitioners remain entirely unconvinced the disorder is real, viewing all acute cases as typical eczema or other known dermatological conditions. This clinical doubt results in diagnostic delays, unsuitable therapies and significant emotional suffering for people experiencing physical symptoms. The growing visibility of TSW on online platforms has highlighted this diagnostic void, prompting researchers to examine the experiences reported by vast numbers of individuals, even as the healthcare profession continues to disagree on the appropriate response.
- Signs may develop abruptly in people with previously stable eczema managed by steroid creams
- Patients often face scepticism from healthcare professionals who attribute worsening to typical eczema exacerbations
- Healthcare providers remain divided on whether TSW is a real disorder or severe eczema exacerbation
- Lack of diagnostic criteria means numerous patients struggle to access suitable care and support
- Online platforms has magnified voices of patients, with TSW hashtags reaching more than one billion views worldwide
Racial Inequities in Diagnosis and Care
The diagnostic difficulties surrounding TSW become even more pronounced amongst those with darker complexions, where symptoms can be significantly harder to identify visually. Erythema and inflammatory responses, the defining features of TSW in people with lighter skin, appear differently across different ethnic groups, yet many assessment protocols remain focused on how the condition appears in white patients. This gap means that Black, Asian and other people of colour experiencing TSW commonly experience significantly extended timeframes in identification and acceptance. Clinical practitioners trained chiefly via manifestations in lighter-skinned individuals may fail to recognise the characteristic signs, leading to continued misidentification and incorrect management approaches that can intensify distress.
Research into TSW has traditionally overlooked the experiences of people with darker complexions, sustaining a pattern where their symptoms remain insufficiently documented and inadequately researched. The online discussions shaping TSW discourse have been predominantly influenced by individuals with lighter complexions, risking distortion of clinical knowledge and community understanding. As Professor Sara Brown’s groundbreaking UK study progresses, ensuring diverse representation amongst participants will be crucial to developing truly inclusive diagnostic frameworks and therapeutic strategies. Without deliberate efforts to centre the experiences of diverse populations, treatment inequalities in TSW identification and care risk widening further, leaving vulnerable populations without sufficient assistance or solutions.
| Skin Tone | TSW Appearance |
|---|---|
| Light/Fair | Bright red inflammation, visible flushing and erythema across affected areas |
| Medium/Olive | Darker red or brownish discolouration with less pronounced visible redness |
| Dark/Deep | Purple-toned or ashen discolouration, with inflammation appearing as hyperpigmentation or hypopigmentation |
| Very Dark | Subtle changes in skin texture and tone, with inflammation manifesting as dark patches or loss of pigmentation |
Emerging Research and Care Approaches Developing
Leading UK Research Project Underway
Professor Sara Brown’s groundbreaking research at the University of Edinburgh marks a turning point for TSW sufferers seeking validation and comprehension. Supported by the National Eczema Society, the study has brought together hundreds of participants in the UK to investigate the underlying mechanisms driving topical steroid withdrawal. By examining symptoms, saliva samples and skin biopsies, researchers seek to identify why some people experience TSW whilst others on identical steroid regimens do not. This scientific scrutiny marks a important transition from dismissal to rigorous examination.
The research team collaborating with Dr Alice Burleigh from patients’ support organisation Scratch That, brings both medical knowledge and personal experience to the investigation. Their partnership approach accepts that people with the condition hold essential understanding into their health situations. Professor Brown has observed trends in TSW that cannot be accounted for by conventional eczema understanding, including characteristic “elephant skin” thickening, extreme shedding and distinctly marked areas of inflammation. The research findings could significantly transform how doctors approach diagnosis and management of this serious condition.
Treatment Options and Associated Limitations
At present, treatment options for TSW are quite limited and frequently inadequate. Many healthcare professionals persist in prescribing topical steroids despite evidence implying they might intensify symptoms in those predisposed. Some patients note transient relief from emollients, antihistamines and oral medications, though results vary widely. Dermatologists are split on optimal management strategies, with some advocating complete steroid cessation whilst others advocate phased withdrawal. This lack of consensus leaves patients navigating their treatment journeys predominantly by themselves, relying heavily on peer support networks and online communities for advice.
Psychological support and specialist dermatological care may provide advantages, yet access remains patchy across the NHS. Some patients have investigated complementary methods including changes to diet, managing environmental factors and holistic therapies, though scientific evidence validating such approaches remains sparse. The lack of established clinical protocols means treatment decisions often depend on individual dermatologist experience and patient preference rather than research-informed standards. Until robust research produces definitive answers, TSW sufferers frequently describe feeling abandoned by conventional medicine.
- Emollients and moisturisers to maintain the skin’s protective barrier and minimise water loss
- Antihistamine medications to control pruritus and related sleep disruption during flare-ups
- Systemic corticosteroids or immunosuppressants for severe cases under specialist supervision
- Mental health support to address emotional distress and worry stemming from prolonged skin suffering
Sounds of Optimism and Resolve
Despite the ambiguity surrounding TSW and the often dismissive perspectives from healthcare professionals, patients are drawing strength in community and shared experience. Digital support communities have emerged as lifelines for those struggling with the condition, providing practical guidance and validation when traditional medicine has failed them. Many sufferers recount the point at which they found the TSW hashtag as transformative—finally finding others with the same symptoms and realising they were not alone in their suffering. This collective voice has been powerful enough to spark the first serious research efforts, showing that patient-led campaigns can drive medical progress even when established institutions remain sceptical.
Bethany Gamble and those facing comparable challenges are committed to draw attention and push for appropriate acknowledgement of TSW within the medical community. Their willingness to recount personal stories of their struggles on social media has made discussions more commonplace around a disorder that numerous physicians still decline to recognise. These individuals are not waiting passively for responses; they are actively participating in research studies, documenting their symptoms carefully, and demanding that their accounts be treated with respect. Their determination in the midst of chronic suffering and medical gaslighting provides encouragement that responses might prove to be within grasp, and that upcoming sufferers will receive the acknowledgement and treatment they so desperately need.
- Patient-led research initiatives are addressing shortcomings left by traditional medical institutions and advancing knowledge of TSW
- Online communities provide psychological assistance, actionable management techniques, and peer validation for affected individuals globally
- Campaign work are gradually shifting medical perception, prompting dermatologists to examine rather than overlook individual accounts
